yujingr

ABT: key level rejected, again

yujingr Updated   
NYSE:ABT   Abbott Laboratories
Neutral outlook for now.
ABT may need a strong catalyst to push it over the key level.

Current price is good for profit taking but not for long entries.

Weak breakthroughs of the key level resistance may provide short term opportunities to short.

Key level:
$91.8
Comment:
Still struggling near the key level. No momentous breakthroughs. Neutral

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.